KGF (Keratinocyte Growth factor) has been found to induce proliferation and differentiation of alveolar type II cells in vitro. In addition, KGF prevents lung injury when given prophylatically in several models of lung injury including bleomycin, radiation, and hydrogen peroxide. However, the mechanisms whereby KGF mediates these effects are unknown. Our hypothesis is that KGF mediates, at least in part these actions by inducing type II cell differentiation using distal effectors of the PI3Kinase signaling cascade. We will study signal transduction pathways of rat alveolar type II cells in primary cultures. Understanding these signaling mechanisms would provide potential targets for the treatment of lung injury.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32HL071424-01
Application #
6551456
Study Section
Special Emphasis Panel (ZRG1-F10 (20))
Program Officer
Colombini-Hatch, Sandra
Project Start
2002-07-10
Project End
Budget Start
2002-07-10
Budget End
2003-07-09
Support Year
1
Fiscal Year
2002
Total Cost
$54,352
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206